Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021) - MRH

The report entitled Global Long Acting Injectable Antipsychotic Market: Size, Trends & Forecasts (2017-2021), provides analysis of the global injectable antipsychotic market, with a detailed analysis of market size and growth, and segmentation of the industry.

The report also includes a detailed regional analysis of the long-acting injectable antipsychotic market in the region of the US. Under competitive landscape, different products in the long-acting injectable antipsychotic market have been compared on the basis of different parameters such as dosing frequency, patent expiry, injection sites, label, storage, needles and available strengths. Also, a financial comparison of long-acting injectable market players in the US has been done.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. The growth of the overall global long-acting injectable antipsychotic market has also been forecasted for years 2017-2021, taking into consideration the previous growth patterns, the growth drivers, and the current and future trends.

Johnson & Johnson, Eli Lily, and Company, Alkermes Public Limited Company, and Lundbeck are some of the key players operating in the global long-acting injectable antipsychotic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Country Coverage

The US

Company Coverage

Johnson & Johnson
Eli Lily and Company
Alkeremes Public Limited Company
Lundbeck

Executive Summary

Anti-psychotic refers to a class of medicine used for the treatment of psychosis and various other emotional and mental conditions. Psychosis consist of delusions, hallucinations, paranoia and disordered thought. It is a condition in which a person experiences thought disorder and personality changes. Long-acting injectable antipsychotics are a sub type of antipsychotics which were primarily developed to improve the treatment of schizophrenia.

The global long acting injectable anti-psychotic market can be studied on the basis of different products and on the basis of prescription. These products are different types of long acting injectable anti-psychotic namely Invega Sustenna/ Trinza, Risperdal Consta, Abilify Maintena, Zyprexa, Aristada and much more.

The global long-acting injectable anti-psychotic market is expected to increase at a healthy rate during the forecast period (2017-2021). The global long-acting injectable anti-psychotic market is supported by various growth drivers, such as increasing cases of schizophrenia, rising number of bipolar disorder patients and non-adherence to oral anti-psychotic.

Browse Full Report with TOC: http://www.marketresearchhub.com/report/global-long-acting-injectable-anti-psychotic-market-size-trends-and-forecasts-2017-2021-report.html

However, side effect associated with anti-psychotic and patent expiry of some of the leading brands are some of the challenges faced by the market. Aging dernography, grant of approval to Trevicta in European Commission, third party proprietary technologies and label expansion of Abilify Maintena are some of the latest trends in the global long acting injectable anti-psychotic market.

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub/
LinkedIn: https://www.linkedin.com/company/market-research-hub/
Facebook: https://www.facebook.com/MarketResearchHub/

This release was published on openPR.